VEGZELMA FDA approval date

The FDA approved VEGZELMA on 27 Sep 2022.

FDA approval date
27 Sep 2022

Drug identity has not yet been verified against registry records

Also recorded as BEVACIZUMAB-ADCD

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-09-27DayVEGZELMAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761268", "applicant_as_listed_by_fda": "CELLTRION", "brand_names": ["VEGZELMA"], "active_ingredients": ["BEVACIZUMAB-ADCD"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220927", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026